Clinical relevance of IL-6 and lactate levels within 24 hours of ICU admission of COVID-19 patients in predicting mortality rate

被引:1
|
作者
Nugroho, Andy [1 ]
Santoso, Sugeng Budi [1 ]
Permana, Septian Adi [1 ]
Hapsari, Paramita Putri [1 ]
Sitompul, Harles [1 ]
机构
[1] Sebelas Maret Univ, Dr Moewardi Gen Hosp, Dept Anesthesiol & Intens Therapy, Fac Med, Surakarta, Cent Java, Indonesia
关键词
IL-6; Lactate; ICU; COVID-19; SARS-CoV-2; CORONAVIRUS DISEASE 2019;
D O I
10.35975/apic.v26i5.2032
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background & objective: Patients with COVID-19 have Acute Respiratory Distress Syndrome (ARDS) which progresses to lung edema and disorders of the liver, kidneys and heart associated with cytokine storms, which are the body's immune response to SARS-CoV-2. SARS-CoV-2 patients showed clinical neutrophilia, increased D-Dimer and increased IL-6. In addition, increased lactate dehydrogenase and increased aminotransferase are often found. This study aimed to analyze the clinical relevance of increased IL-6 and lactate in the first 24 hours of ICU-admission of COVID-19 patients in predicting mortality rate. Methodology: This study was a retrospective cohort design. The study was conducted in the Intensive Care Unit (ICU) of Dr. Moewardi Surakarta Hospital. The study was conducted by tracing the medical records of COVID-19 patients treated in the ICU of Dr. Moewardi Surakarta Hospital during the period of March 1, 2020 to March 31, 2021 that met the admission criteria. The patient's mortality assessment is seen as the patient's condition for a maximum of 30 days after discharge from the hospital. Results: Variables that meet the regression model are the lactate levels (OR = 3,143; P = 0.064) as well as the IL-6 levels (OR = 25.41; p<0.001). AUC score of 86.9% with significance of < 0.001. IL-6 levels and lactate levels in the study can be used as predictors of mortality rates with 95.7% sensitivity and 60% specificity. Lactate levels in COVID-19 cases in severe cases can be related to lung damage and tissue damage. Lactate levels have also been recognized as a marker of poor prognosis in patients with COVID- 19. IL-6 as a predictor of mortality risk has been recognized and the administration of IL-6 inhibitors in COVID-19 patients may lower the risk of mortality. Conclusion: Raised IL-6 and lactate levels in this study can be a predictor of the mortality rate of COVID-19 patients within 24 hours of ICU-admission.
引用
收藏
页码:689 / 694
页数:6
相关论文
共 50 条
  • [1] D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In-Hospital Mortality in Patients with COVID-19 Pneumonia
    Milenkovic, Marija
    Hadzibegovic, Adi
    Kovac, Mirjana
    Jovanovic, Bojan
    Stanisavljevic, Jovana
    Djikic, Marina
    Sijan, Djuro
    Ladjevic, Nebojsa
    Palibrk, Ivan
    Djukanovic, Marija
    Velickovic, Jelena
    Ratkovic, Sanja
    Brajkovic, Milica
    Popadic, Viseslav
    Klasnja, Slobodan
    Toskovic, Borislav
    Zdravkovic, Darko
    Crnokrak, Bogdan
    Markovic, Olivera
    Bjekic-Macut, Jelica
    Aleksic, Aleksandra
    Petricevic, Simona
    Memon, Lidija
    Milojevic, Ana
    Zdravkovic, Marija
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [2] IL-6 Serum Levels in COVID-19 Patients With Vertigo
    Kitsos, Dimitrios
    Tzartos, John
    Korres, George
    Giannopapas, Vasileios
    Riga, Maria
    Stergiou, Christos
    Tsoga, Anthi
    Grigoropoulos, Christos
    Paraskevas, Georgios
    Zompola, Christina
    Nikolopoulos, Thomas
    Giannopoulos, Sotirios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [3] Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients
    Bilgir, Ferda
    Calik, Sebnem
    Demir, Ismail
    Bilgir, Oktay
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 : 67 - 73
  • [4] Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19
    Sonu Subudhi
    Ashish Verma
    Ankit B. Patel
    C. Corey Hardin
    Melin J. Khandekar
    Hang Lee
    Dustin McEvoy
    Triantafyllos Stylianopoulos
    Lance L. Munn
    Sayon Dutta
    Rakesh K. Jain
    npj Digital Medicine, 4
  • [5] Comparing machine learning algorithms for predicting ICU admission and mortality in COVID-19
    Subudhi, Sonu
    Verma, Ashish
    Patel, Ankit B.
    Hardin, C. Corey
    Khandekar, Melin J.
    Lee, Hang
    McEvoy, Dustin
    Stylianopoulos, Triantafyllos
    Munn, Lance L.
    Dutta, Sayon
    Jain, Rakesh K.
    NPJ DIGITAL MEDICINE, 2021, 4 (01)
  • [6] Clinical significance of IL-6 in severe and critical COVID-19 patients
    Kawamata, Takaya
    Tanino, Yoshinori
    Wang, Xintao
    Nikaido, Takefumi
    Sato, Yuki
    Togawa, Ryuichi
    Watanabe, Natsumi
    Saito, Koshi
    Kazama, Kentaro
    Harigane, Rina
    Yamada, Ryuki
    Tomita, Hikaru
    Rikimaru, Mami
    Morimoto, Julia
    Minemura, Hiroyuki
    Saito, Junpei
    Kanazawa, Kenya
    Shibata, Yoko
    RESPIROLOGY, 2023, 28 : 136 - 136
  • [7] ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
    Vassiliou, Alice G.
    Keskinidou, Chrysi
    Jahaj, Edison
    Gallos, Parisis
    Dimopoulou, Ioanna
    Kotanidou, Anastasia
    Orfanos, Stylianos E.
    CELLS, 2021, 10 (01) : 1 - 13
  • [8] Predicting the Need for ICU Admission in COVID-19 Patients Using XGBoost
    Ezz, Mohamed
    Elbashir, Murtada K.
    Shabana, Hosameldeen
    CMC-COMPUTERS MATERIALS & CONTINUA, 2021, 69 (02): : 2077 - 2092
  • [9] Usefulness of Hospital Admission Chest X-ray Score for Predicting Mortality and ICU Admission in COVID-19 Patients
    Hoang-Thi, Trieu-Nghi
    Tran, Duc-Tuan
    Tran, Hai-Dang
    Tran, Manh-Cuong
    Ton-Nu, Tra-My
    Trinh-Le, Hong-Minh
    Le-Huu, Hanh-Nhi
    Le-Thi, Nga-My
    Tran, Cong-Trinh
    Le-Dong, Nhat-Nam
    Dinh-Xuan, Anh-Tuan
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [10] Comment on "Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients"
    Liu, Liwen
    Li, Xiaofei
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2021, 67 (10): : 1518 - 1518